Related Experiment Videos
Reporter gene imaging: potential impact on therapy.
Inna Serganova1, Ronald Blasberg
1Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Nuclear Medicine and Biology
|October 26, 2005
Summary
Molecular-genetic imaging using positron emission tomography (PET) enables noninvasive monitoring of gene therapy and cell-based treatments. This technology tracks gene expression, cell trafficking, and molecular events in vivo for clinical applications.
Area of Science:
- Molecular imaging
- Genetics
- Biotechnology
Background:
- Positron emission tomography (PET)-based molecular-genetic imaging has rapidly emerged as a new discipline.
- It integrates molecular and cell biology research with imaging technologies like nuclear, magnetic resonance, and optical methods.
- The convergence of these fields drives advancements in multi-modality imaging.
Purpose of the Study:
- To review the principles and applications of indirect molecular-genetic imaging strategies using reporter genes and probes.
- To discuss the translation of reporter gene imaging to clinical applications.
- To highlight potential future patient imaging studies.
Main Methods:
- Utilizing reporter gene constructs driven by constitutive or inducible promoters.
- Employing cell-specific promoters to restrict transgene expression.
- Developing complementary reporter probes for detection.
Main Results:
- Reporter gene imaging allows monitoring of gene therapy vectors, transduction efficacy, and adoptive cell-based therapies.
- Inducible promoters can regulate reporter gene expression to study endogenous cellular processes.
- Reporter systems can be designed to monitor mRNA stabilization and protein-protein interactions.
Conclusions:
- Noninvasive in vivo reporter gene imaging offers quantitative monitoring of gene therapy vector efficacy and transgene expression.
- It enables tracking of cell trafficking, targeting, replication, and activation in adoptive therapies.
- Future applications include assessing endogenous molecular events via diagnostic transductions.